Global Weight Loss Dietary Supplements Market

Global Weight Loss Dietary Supplements Market Overview

• The Global Weight Loss Dietary Supplements Market Size is anticipated to exceed USD 62.68 Billion by 2033, growing at a CAGR of 6.00% from 2023 to 2033.
• The market growth is rising due to the rising obesity rates, increasing health consciousness, growing fitness trends, celebrity and influencer endorsements, expanding e-commerce channels, demand for natural ingredients, busy lifestyles, preventive healthcare focus, and product innovation.  

Major vendors in the Global Weight Loss Dietary Supplements Market 

Abbott Laboratories, Glanbia Plc, GlaxoSmithKline Plc., Stefan Company, GNC Holdings Inc, Amway Corporation, Vitaco Health Limited, ABH Pharma Inc., Herbalife International, Inc, Atlantic Multipower UK Ltd., Nu Skin Enterprises, Inc., Shaklee Corporation, Vitacost.com Inc., and others.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Decision Advisors has segmented the global weight loss dietary supplements market based on the below-mentioned segments:

Global Weight Loss Dietary Supplements Market, By Form

• Soft Gel/Pills
• Powder
• Liquid

 Global Weight Loss Dietary Supplements Market, By Distribution Channel

• Pharmacies Drug Store
• Health & Beauty Store
• Hypermarket/Supermarket
• Online Sales
• Other Sales Channel

Global Weight Loss Dietary Supplements Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa